Related Experiment Video
Updated: Apr 8, 2026
18:11
Quantifying Synapses: an Immunocytochemistry-based Assay to Quantify Synapse Number
Published on: November 16, 2010
36.9K
Astrocyte-Derived PTPRZ1 Regulates Excitatory Synapse Density in the Mouse Cortex
Alex R Eaker1, Hayli E Spence-Osorio1, Madelyn G Coble1,2
1Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599.
Eneuro
|April 6, 2026
Summary
Protein tyrosine phosphatase receptor type Z1 (PTPRZ1) plays a key role in astrocyte development and synapse formation in the brain. Deleting PTPRZ1 in astrocytes reduced excitatory synapse density, highlighting its importance in neurodevelopment.
Area of Science:
- Neuroscience
- Developmental Biology
- Cell Biology
Background:
- Protein tyrosine phosphatase receptor type Z1 (PTPRZ1) is highly expressed in developing astrocytes, but its specific functions remain unclear.
- Altered PTPRZ1 expression is implicated in neurological disorders like schizophrenia and glioblastoma.
Purpose of the Study:
- To investigate the function of PTPRZ1 in astrocytes during brain development.
- To generate a conditional knockout mouse model for studying astrocyte-specific PTPRZ1 function.
Main Methods:
- Utilized an astrocyte-neuron co-culture system to assess PTPRZ1 knockdown effects on astrocyte morphology.
- Generated a conditional knockout mouse model to delete PTPRZ1 in astrocytes postnatally.
- Analyzed astrocyte morphology and synapse marker density in the visual cortex of knockout mice.
Main Results:
- Knockdown of PTPRZ1 in astrocytes impaired branching morphogenesis in vitro.
- Astrocyte-specific PTPRZ1 deletion in mice resulted in subtle changes in astrocyte morphology.
- A reduction in co-localized excitatory synapse markers was observed in the visual cortex of knockout mice.
Conclusions:
- Astrocyte PTPRZ1 is crucial for both astrocyte morphogenesis and synaptogenesis during brain development.
- The generated PTPRZ1 conditional knockout mouse is a valuable tool for studying PTPRZ1's role in neurodevelopment and neuropathology.
- PTPRZ1 is an emerging therapeutic target for glioblastoma and neurodegenerative diseases.
